Literature DB >> 22863650

Defining research priorities in complementary medicine in oncology.

M Robotin1, C Holliday, A Bensoussan.   

Abstract

OBJECTIVES: The high usage of complementary and alternative medicines (CAM) by cancer patients is increasing, despite limited research available to support their use. Therefore identifying research priorities that can inform the evidence base for CAM treatment is relevant for many stakeholders, including funders, researchers and consumers. DESIGN AND
SETTING: Integrative medicine experts, oncologists with interest in CAM research, consumer representatives and CAM practitioners and researchers took part in a modified Delphi process conducted online over three rounds. In round 1 each participant recommended up to five CAM research priorities, which were collated and ranked in round 2 by their potential usefulness in cancer care, using a Likert scale. In round 3, participants ranked the remaining propositions by their ability to impact cancer care in Australia. The lowest ranking priorities were eliminated at the completion of each round.
RESULTS: From the 122 propositions originally submitted by the 27 participants, the highest scoring ones included: studying interactions between biologically based CAM and conventional cancer treatments, examining CAM effects on quality of life, identifying effective communication strategies around CAM, studying the role of physical activity in symptom relief and cancer prevention and exploring the role of acupuncture in cancer care.
CONCLUSION: This method of research prioritisation achieved consensus of opinion among a very diverse group of stakeholders, invited to collaborate around a highly polarising topic. Through a structured interaction, the group agreed on a priority research list acceptable to all stakeholders, which can serve as a blueprint for CAM research in oncology in Australia.
Copyright © 2012 Elsevier Ltd. All rights reserved.

Entities:  

Mesh:

Year:  2012        PMID: 22863650     DOI: 10.1016/j.ctim.2012.04.001

Source DB:  PubMed          Journal:  Complement Ther Med        ISSN: 0965-2299            Impact factor:   2.446


  5 in total

1.  Guidance for establishing an integrative oncology service in the Australian healthcare setting-a discussion paper.

Authors:  Suzanne J Grant; Jennifer Hunter; Alan Bensoussan; Geoff P Delaney
Journal:  Support Care Cancer       Date:  2017-09-01       Impact factor: 3.603

2.  Canadian integrative oncology research priorities: results of a consensus-building process.

Authors:  L C Weeks; D Seely; L G Balneaves; H S Boon; A Leis; D Oneschuk; S M Sagar; M J Verhoef
Journal:  Curr Oncol       Date:  2013-08       Impact factor: 3.677

3.  Use of Complementary and Alternative Medicine (CAM) as Part of the Oncological Treatment: Survey about Patients' Attitude towards CAM in a University-Based Oncology Center in Germany.

Authors:  Kerstin A Kessel; Sabrina Lettner; Carmen Kessel; Henning Bier; Tilo Biedermann; Helmut Friess; Peter Herrschbach; Jürgen E Gschwend; Bernhard Meyer; Christian Peschel; Roland Schmid; Markus Schwaiger; Klaus-Dietrich Wolff; Stephanie E Combs
Journal:  PLoS One       Date:  2016-11-03       Impact factor: 3.240

4.  The effect of electroacupuncture on osteosarcoma tumor growth and metastasis: analysis of different treatment regimens.

Authors:  Branden A Smeester; Mona Al-Gizawiy; Elaine E O'Brien; Marna E Ericson; Jennifer L Triemstra; Alvin J Beitz
Journal:  Evid Based Complement Alternat Med       Date:  2013-10-21       Impact factor: 2.629

5.  Inhibition of Triple-Negative Breast Cancer Tumor Growth by Electroacupuncture with Encircled Needling and Its Mechanisms in a Mice Xenograft Model.

Authors:  Xin Jiang; Yehong Tian; Lin Xu; Qiaoli Zhang; Yuxiang Wan; Xuewei Qi; Bo Li; Jing Guo; Weiliang Sun; Aiping Luo; Jinchang Huang; Xiaohong Gu
Journal:  Int J Med Sci       Date:  2019-11-09       Impact factor: 3.738

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.